Treatment of 52 y/o Post-Menopausal Woman HER2- Breast Cancer & Bone Mets: Clinical Significance of Loco-Regional Recurrence & Data on Stereotactic Ablative Radiotherapy

14 views
March 2, 2020
0 Comments
Login to view comments. Click here to Login